Lead (Pb 21 ) exposure is known to affect presynaptic neurotransmitter release in both in vivo and cell culture models. However, the precise mechanism by which Pb 21 impairs neurotransmitter release remains unknown. In the current study, we show that Pb 21 exposure during synaptogenesis in cultured hippocampal neurons produces the loss of synaptophysin (Syn) and synaptobrevin (Syb), two proteins involved in vesicular release. Pb 21 exposure also increased the number of presynaptic contact sites. However, many of these putative presynaptic contact sites lack Soluble NSF attachment protein receptor complex proteins involved in vesicular exocytosis. Analysis of vesicular release using FM 1-43 dye confirmed that Pb 21 exposure impaired vesicular release and reduced the number of fast-releasing sites. Because Pb 21 is a potent N-methyl-D-aspartate receptor (NMDAR) antagonist, we tested the hypothesis that NMDAR inhibition may be producing the presynaptic effects. We show that NMDAR inhibition by aminophosphonovaleric acid mimics the presynaptic effects of Pb 21 exposure. NMDAR activity has been linked to the signaling of the transsynaptic neurotrophin brainderived neurotrophic factor (BDNF), and we observed that both the cellular expression of proBDNF and release of BDNF were decreased during the same period of Pb 21 exposure. Furthermore, exogenous addition of BDNF rescued the presynaptic effects of Pb 21 . We suggest that the presynaptic deficits resulting from Pb 21 exposure during synaptogenesis are mediated by disruption of NMDAR-dependent BDNF signaling.
Effective brain function requires synapses to undergo fast and efficient neurotransmitter release tightly coupled to calcium (Ca 2þ ) signaling. Neurotransmitter release occurs at presynaptic active zones (PAZ), highly specialized regions juxtaposed to postsynaptic densities. During development, packets of preassembled PAZ proteins arrive at nascent presynaptic sites (Ziv and Garner, 2004) . These packets contain cytomatrix structural proteins, such as Bassoon (Bass) and Piccolo, which provide essential scaffolding to organize the complex machinery required for vesicular release (Shapira et al., 2003) . Concurrently or following the arrival of these scaffolding proteins, synaptic neurotransmitter vesicles are recruited and primed for vesicular release. Ca 2þ -sensing vesicular proteins, such as synaptotagmin (Syt), couple vesicular release to Ca 2þ entry (Chicka et al., 2008) . The PAZ is thus exquisitely designed to provide fast efficient neurotransmission, and disruption of this process can impair neuronal development and brain function (Ziv and Garner, 2004) .
Lead (Pb 2þ ) exposure affects neurotransmission both in vivo and in vitro. Chronic Pb 2þ exposure decreases evoked release of glutamate (Glu) and c-aminobutyric acid (GABA) in adult rats exposed during development (Lasley and Gilbert, 2002) and in hippocampal cultures and slices acutely exposed to Pb 2þ (Braga et al., 1999; Xiao et al., 2006) . The mechanism for these effects remains unknown, although several studies have identified the ability of Pb 2þ to interact with intracellular proteins, particularly Ca 2þ -binding proteins. For example, Pb 2þ can bind Syt-1 with 1000-fold higher affinity than Ca 2þ , which may prevent detection of Ca 2þ signaling essential to neurotransmission (Bouton et al., 2001) . Pb 2þ can interact with other intracellular Ca 2þ -binding proteins, suggesting that Ca 2þ mimicry may be a common characteristic of Pb 2þ toxicity (Marchetti, 2003) . Another hypothesis is that Pb 2þ may interfere with Ca 2þ signals by inhibiting Ca 2þ channels (Braga et al., 1999; Peng et al., 2002; Xiao et al., 2006) . Inhibition of voltage-gated Ca 2þ channels may prevent the necessary rise in internal Ca 2þ required for fast Ca 2þ -dependent vesicular release, thus interfering with neurotransmission. In conclusion, although several hypotheses exist, the targets responsible for the presynaptic effects of Pb 2þ remain unknown.
The present study sought to characterize the effects of Pb 2þ on PAZ composition and vesicular release during the period of synaptogenesis of hippocampal neurons in culture. By using a hippocampal culture system, we gained the high degree of spatial and temporal resolution needed to detect changes at the synaptic level. We show that Pb 2þ exposure during synaptogenesis (day in vitro [DIV]7-12) results in specific effects on the expression of key presynaptic proteins involved in vesicular release. In particular, Pb 2þ exposure reduces the levels of synaptophysin (Syn) and its binding partner, synaptobrevin (Syb), without affecting the levels of Syt. Furthermore, Pb 2þ exposure increases the number of nascent presynaptic contact sites, although a portion of these sites appear to lack vesicular release machinery proteins and may be presynaptically silent. We further demonstrate that vesicular release is impaired after Pb 2þ exposure, with a decrease in the number of fast-releasing sites.
Pb 2þ is a potent N-methyl-D-aspartate receptor (NMDAR) antagonist (Alkondon et al., 1990; Gavazzo et al., 2008; Guilarte et al., 1994) , and we investigated whether NMDAR signaling may be involved as a potential mechanism for the effects of Pb 2þ on presynaptic function. Inhibition by the NMDAR antagonist aminophosphonovaleric acid (APV) during synaptogenesis mimicked the effects of Pb 2þ on PAZ proteins. NMDAR activity has been shown to be essential for presynaptic plasticity and PAZ maturation through activitydependent retrograde signaling (Tao and Poo, 2001; Walz et al., 2006) . In particular, the signaling of brain-derived neurotrophic factor (BDNF), a member of the neurotrophin family, has been linked to activation of NMDARs (Jiang et al., 2005; Vanhoutte and Bading, 2003) . Both synthesis and release of BDNF has been shown to occur in postsynaptic neurons in an NMDAR-dependent manner to act on presynaptic targets, driving presynaptic maturation (Jiang et al., 2005; Walz et al., 2006) . Thus, it is possible that postsynaptic inhibition of NMDARs by Pb 2þ disrupts activity-dependent retrograde signaling resulting in impaired presynaptic development. Here, we report that both the levels of intracellular proBDNF protein and the release of BDNF are decreased in Pb 2þ -exposed neurons and that exogenous addition of BDNF can rescue the effects of Pb 2þ on both PAZ protein levels and vesicular release. Our data support the hypothesis that disruption of NMDAR-dependent BDNF signaling is involved in the mechanism of the presynaptic effects of Pb 2þ .
METHODS
Animal care and use statement. All animal studies were approved by the Johns Hopkins University Animal Care and Use Committee and were carried out in accordance with the Guide for Care and Use of Laboratory Animals as adopted and promulgated by the U.S. National Institutes of Health.
Cell culture. Primary hippocampal cultures were obtained from E18 Sprague-Dawley rat pups (Harlan, Frederick, MD) . Low-density cultures (14,000 cells/cm 2 ) were seeded and maintained as described elsewhere (Chowdhury et al., 2006) . Feeding medium was composed of fetal bovine serum (1% vol/vol; Hyclone-Thermo Scientific, Waltham, MA), 2mM glutamax (Invitrogen, Carlsbad, CA), and penicillin/streptomycin (100 U each; Invitrogen) in neurobasal medium (Invitrogen). Pb-acetate (95% pure; Sigma Aldrich, St Louis, MO) and/or APV (! 98% pure; Sigma) were added to the feeding medium on DIV7, whereas vehicle was added to control cultures. Neurons were harvested 5 days after dosing (DIV12), without media exchange between DIV7 and DIV12.
Pb
2þ analysis. Samples of Pb 2þ stock solutions (100 and 10lM in feeding medium) used to treat cells were sent periodically to ESA Laboratories, Inc. (Magellan Biosciences, Chelmsford, MA) for atomic absorption spectroscopy. Reports from ESA Laboratories showed that our 100 and 10lM Pb 2þ stock solutions were within the intended range (91.4 ± 4.9lM, n ¼ 9 samples and 9.6 ± 0.4lM, n ¼ 4 samples, respectively).
MTS cell viability assay. 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS), inner salt assays, were performed as per the manufacturer's instructions (CellTiter 96 Aqueous NonRadioactive Cell Proliferation Assay; Promega, Madison, WI). Briefly, hippocampal neurons were plated in 96-well plates at 14,000 cells/cm 2 . Cells were exposed to 1.0lM Pb 2þ for 5 days or to 100lM glutamate for 24 h as a positive cytotoxic control. After the exposure period, 20 ll of the MTS reagent was added to the wells for 2 h at 37°C. Absorbencies were read at 490 nm using a multichannel plate reader.
BDNF release. Sandwich ELISAs were performed on DIV12 cell culture medium using the BDNF Emax ImmunoAssay System kit (Promega) according to the manufacturer's instructions. BDNF content was interpolated from standard curves for each plate (linear range of 7.8-500 pg/ml). BDNF protein content was divided by total protein for each sample to determine the number of picograms of peptide per microgram of total protein. Samples were normalized to control and analyzed by Student's two-tailed t-test.
Protein harvesting and Western blotting. Cells were harvested in a sucrose buffer (in mM: sucrose 300, NaCl 75, Tris-HCl 10, EDTA 20, Ethylene glycolbis(2-aminoethylether)-/N,N,N//'//,N//'/-tetraacetic acid 20, and 0.25% [wt/vol] deoxycholic acid) on ice. Protein quantification was performed using the DC protein assay (Bio-Rad, Hercules, CA) and equal protein weight in 30 ll sample buffer (6% glycerol [vol/vol] ; 30mM Tris, pH 6.8; 1.2mM EDTA; 1.2% SDS [wt/vol]; and 8.64mM b-mercaptoethanol) was loaded in each well of a 12 þ 2 well precast Tris-HCl gel (Criterion; Bio-Rad). Gels were run at 50 mA until sample buffer ran off the gel and transferred overnight at 120 mA. Membranes were incubated in the appropriate primary antibodies (1:200 synaptophysin, Sigma S5768; 1:1000 proBDNF, Millipore AB5613P; and 1:1000 actin, Santa Cruz sc1616, Santa Cruz, CA) diluted in blocking solution overnight at 4°C. The membranes were visualized using the Odyssey imaging system (LI-COR, Lincoln, NE). The integrated intensity of the protein of interest was normalized to actin levels from the same blot.
Western blots were performed with duplicate sample loading. The average of the duplicates was used as the single datum point for an independent trial. Three or more independent trials were pooled and subjected to one-way ANOVA.
Immunocytochemistry. On DIV12, neurons grown on glass coverslips were initially fixed in 4% paraformaldehyde (vol/vol), 4% sucrose (wt/vol) in PBS followed by secondary fixation in ice-cold methanol. Cells were permeabilized in 0.2% Triton in PBS (vol/vol) and blocked in 10% normal goat serum in PBS (vol/vol). Proteins investigated included presynaptic cytomatrix markers (Bass), synaptic vesicle proteins (vesicular glutamate transporter 1: VGLUT1, vesicular GABA transporter: VGAT, Syn, Syb, and Syt), and a marker of the dendritic arbor (microtubule-associated protein 2 [MAP2]). Samples were incubated in primary antibodies diluted in blocking solution overnight at 4°C using the following dilutions: 1:100 synaptophysin, Santa Cruz sc9112; 1.15 lg/ml Bassoon, Stressgen VAM-PS003, Ann Arbor, MI; 1:1000 MAP2, Santa Cruz sc74421 (mouse); 1:1000 MAP2, MilliporeChemicon AB5622 (rabbit), Billerica, MA; 1:500 VGLUT1, Chemicon 250 NEAL ET AL. MAB5502; 1:500 VGAT Synaptic Systems 131011, Goettingen, Germany; 1:500 Synaptobrevin Synaptic Systems 104202; and 1:500 Synaptotagmin-1 Synaptic Systems 105001. MAP2 was used as a colabel in several double-label immunocytochemistry experiments to aid visualization of the dendritic arbor, and based on the antibody of interest (rabbit or mouse), the alternate species of MAP2 antibody was used (rabbit or mouse). After incubation in primary antibodies, the neurons were washed in PBS and incubated in the appropriate secondary antibodies (10 lg/ml Alexafluor488 or Alexafluor594; InvitrogenMolecular Probes, Carlsbad, CA) diluted in blocking solution at room temperature. Following another series of washes in PBS, the coverslips were mounted onto slides in ProLong Gold mounting medium (Molecular Probes). Slides were coded to ensure during imaging and analyses that investigators were blinded to the identity of the samples.
Data from three or more independent trials were internally normalized to the average control value, and the normalized data were pooled. Data were then analyzed using one-way ANOVA (Superanova; Abacus Concepts, Piscataway, NJ). Significance was set at p < 0.05, and post hoc analysis utilized Fisher's protected least significant difference (LSD) test. Data comparing a single treatment condition to control were subjected to Student's two-tailed t-tests.
Imaging and image analysis of fixed coverslips. Immunofluorescently labeled neurons were imaged at 363 magnification using a single-point laser scanning confocal microscope (LSM510-Meta; Zeiss, Thornwood, NY) utilizing LSM image software at the Johns Hopkins University School of Medicine Microscope Facility. All coverslips stained under the same conditions were imaged using the same scanning parameters on the same day. Four to seven confocal stacks of single neurons were obtained for each experimental condition. Confocal stacks were projected into single images using the maximum fluorescence. Images were analyzed using Metamorph Offline (Molecular Devices, Downingtown, PA). Images obtained from the same experiment were thresholded at the same level for analysis. Several parameters of synaptic protein expression were measured using integrated morphometry analysis. They include immunofluorescent puncta density (number of puncta per micrometer dendrite), area (average area of puncta), intensity (average gray value of puncta), and total gray value ([TGV] integration of puncta intensity relative to area). Puncta intensity thus measures the average intensity of the fluorescent puncta, whereas puncta TGV gives a semiquantitative measurement of protein quantity. For colocalization analysis, gray scale images at each wavelength for the same neuron were used to select three to six dendritic regions. Selected dendritic regions were at least 10 lm from the cell body, were clearly identifiable as single processes, and could be traced back to the imaged neuron. All processes that fit these criteria in a single image were sampled. Using the tool ''Measure Colocalization,'' the area of colocalized pixels of both wavelengths in these regions was used to calculate the percent colocalization of the cell. Percent colocalization was calculated as follows: Vesicular release of FM 1-43. Live imaging was performed using a 3i spinning disk confocal microscope with a controlled CO 2 /humidity/temperature enclosure at 363 magnification. Glass-bottomed plates (MatTek, Ashland, MA) were rinsed twice in normal bath solution (in mM: 4 MgCl 2 , 2 CaCl 2 , 119 NaCl, 25 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic acid (HEPES), 30 D-glucose, and 2.5 KCl) and loaded with FM 1-43 Dye (10lM; Molecular Probes) in hyperkalemic solution (in mM: 4 MgCl 2 , 2 CaCl 2 , 31.5 NaCl, 25 HEPES, 30 glucose, and 90 KCl) for 90 s. Plates were then rinsed with lowCa 2þ solution twice for 5 min (in mM: 4 MgCl 2 , 119 NaCl, 25 HEPES, 30 glucose, and 2.5 KCl). A final 1-min wash was included using 1mM ADVASEP7 (Sigma), a sulfonated b-cyclodextrin derivative (Kay et al., 1999) Figure 1 shows a representation of the live imaging analysis. To determine the number of sites that released dye during the imaging period, the destained image (Fig. 1B) was subtracted from the first time point of the time-lapse series (Fig. 1A) , generating an image of the cell showing only sites that released dye during the imaging period (Fig. 1C) . Sites were then counted with MetaMorph Offline. Individual release sites were selected after determining that they did not move during the imaging period and that they were among those sites identified as active release sites. Individual rates of release were tracked for release sites and a cell-free region, which was used as an indication of the photobleaching for that image (Fig. 1D) . After subtracting the rate of decay because of photobleaching (Fig. 1E ), the decay from individual sites fit a singleexponential equation:
where k is the decay constant and corresponds to the inverse of s, the mean lifetime. Linearizing the equation by using the natural log allowed direct calculation of s after normalizing each site to its initial intensity ( Fig. 1F) . Equality of distributions was tested using the Kruskal-Wallis ranked sum test (Stata, v9.2; Statacorp, College Station, TX) . To determine what areas of the distribution were driving differences between control and treated conditions, the control distribution was split into four regions based on its quartile values. The same four values were used to divide treatment distributions into quadrants and regions were compared using Pearson's chisquare test. To compare the averaged rate of release between treatments, the fluorescence intensity of each release site at each time point was normalized to its initial fluorescence. Data were then linearized, pooled, and subjected to mixed-effects linear regression with clustering on the cellular level (xtmixed function, Stata v9.2). We used a mixed-effects regression model because we observed a high degree of intra-cell correlation based on the rho (q, interclass correlation) value. A high q value suggested that sites from the same cell were more similar to each other than sites from other cells. Using the xtmixed model allowed us to account for this intra-cell clustering as well as treatment condition, and slopes and intercepts were assumed to be random variables and not fixed effects.
Initial intensity measurements of FM 1-43-positive puncta were performed using morphometric analysis (Metamorph) to record the average gray value at the start of the imaging period for each release site chosen for the above analyses. The sites for each cell were averaged, cells were pooled based on treatment, and data were subjected to two-tailed t-test when comparing only a single treatment group or one-way ANOVA when comparing multiple treatment groups with control.
RESULTS

Loss of the Vesicular Proteins Synaptophysin and Synaptobrevin Following Pb 2þ Exposure during Synaptogenesis
Primary hippocampal neurons grown in culture for DIV7 were exposed to 0-1.0lM Pb 2þ for 5 days and harvested on DIV12. This 5-day time period corresponds to the critical window for synaptogenesis in these cultures (Fletcher et al., 1994) and allowed us to target the effects of Pb 2þ on developing synapses. The level of Pb 2þ used to expose primary hippocampal neurons in this study is of the same magnitude as the concentration of Pb 2þ in the hippocampus DISRUPTION OF SYNAPTIC FUNCTION BY LEAD of animals exposed to Pb 2þ during development (Guilarte et al., 2003) , which corresponds to blood concentrations measured in Pb 2þ intoxicated inner city children. Our aim was to approximate the Pb 2þ exposure in our culture system to levels relevant to contemporary exposures in pediatric populations.
Our first experiments were designed to examine the levels of key presynaptic proteins after Pb 2þ exposure during synaptogenesis. We examined presynaptic proteins involved in synaptic vesicle targeting and/or release (Syn, Syb, and Syt), the presynaptic matrix protein Bass and vesicular neurotransmitter transporters (VGLUT1/VGAT). We first examined Syn because it is a marker commonly used to assess presynaptic elements and is involved in vesicular release (Valtorta et al., 2004) . We performed immunofluorescence confocal imaging for Syn in control and Pb 2þ -treated neurons. The highest level of Pb 2þ used (1.0lM) was determined to be noncytotoxic based on MTS cell viability assays. After exposure to 1.0lM Pb 2þ , cell viability was 99.7 ± 1.1% of control levels, whereas cell viability after exposure to excitotoxic levels of glutamate (100lM) for 24 h, used as a positive control, was significantly reduced to 70.0 ± 4.9% of control (n ¼ 4 independent assays; F 2,9 ¼ 21.72, p < 0.01). , Syn puncta density, area, intensity, and TGV decreased significantly (n ¼ 17-18 neurons per condition from three trials, p < 0.05). Western blots confirmed that Syn protein levels were significantly decreased after Pb 2þ exposure in a concentration-dependent fashion (Figs. 2F and 2G; n ¼ 4 blots, p < 0.05). These data indicate that Pb 2þ exposure during synaptogenesis decreased the levels of the synaptic vesicle protein Syn in the PAZ.
To determine if other proteins associated with the vesicular release machinery were affected by Pb 2þ exposure, we examined the levels of Syb (also called VAMP2) and the Ca 2þ -sensing protein Syt. For these and subsequent studies, we only used the 1.0lM Pb 2þ concentration. Prior to vesicular release, Syn prevents Syb from binding Syntaxin (Reisinger et al., 2004) , but before the vesicle docks to the plasma membrane, Syn dissociates from Syb, allowing Syb to bind Syntaxin and initiate formation of the fusion pore (Südhof and Rothman, 2009; Valtorta et al., 2004) . Figures 3A-C show that Pb 2þ exposure significantly decreased Syb levels but had no effect on Syt levels (Figs. 3D-F) . After exposure to 1lM Pb 2þ , Syb puncta density, area, intensity, and TGV decreased (n ¼ 15 252 neurons per condition from three trials, p < 0.05, two-tailed t-test). These data indicate that while presynaptic vesicles retain normal levels of the Ca 2þ -sensing protein Syt, they lack an essential v-SNARE protein for neurotransmitter release.
To asses the selectivity of the effects of Pb 2þ on the expression of Syn and Syb, we examined other vesicular proteins that are not involved in vesicular release but are associated with neurotransmitter uptake into vesicles. For these studies, we selected the glutamatergic transporter (VGLUT1) and GABAergic transporter (VGAT). We found that unlike VGLUT1, whose expression did not change after Pb 2þ exposure (Figs. 3G-I), VGAT levels were significantly decreased (Figs. 3J-L). Specifically, VGAT puncta area and TGV decreased after Pb 2þ exposure in the absence of changes in VGAT puncta density or intensity (n ¼ 15 neurons per condition from three trials, p < 0.05 by two-tailed t-test for area and TGV). The previous results clearly show that Syn and Syb, and to a lesser extent VGAT, are significantly decreased by Pb 2þ exposure. All the proteins examined thus far were vesicular membrane proteins. Synaptic vesicles may be recruited after the initial formation of the presynaptic cytomatrix and thus may not accurately represent the total number of presynaptic sites, which includes both mature (containing synaptic vesicles) and nascent (lacking synaptic vesicles) sites (Friedman et al., 2000; Ziv and Garner, 2004) . To accurately assess the number of presynaptic sites, including nascent sites, we performed immunofluorescence confocal imaging of the presynaptic cytoskeletal matrix protein Bass. Bass is a large scaffolding protein that arrives at nascent presynaptic contact sites prior to or concurrently with vesicular proteins and may be involved in defining neurotransmitter release sites (Friedman et al., 2000; Shapira et al., 2003; Ziv and Garner, 2004) . Figures 3M-O show that Bass puncta density is significantly increased after exposure to 1lM Pb 2 (n ¼ 15 neurons from three trials, p < 0.05, two-tailed t-test). However, puncta area did not change (p > 0.05) relative to control.
The increase in Bass puncta density suggests that Pb 2þ exposure increases the number of putative presynaptic contact sites. However, Pb 2þ exposure also resulted in decreased expression of Syn and Syb, proteins essential for vesicular release, without affecting the number of glutamatergic and GABAergic inputs. To assess if the increase in putative presynaptic contact sites defined by Bass-positive puncta corresponded to sites that lacked the vesicular proteins Syn exposure significantly increased the number of Bass-positive presynaptic elements that lacked Syn (Bass alone; n ¼ 16 neurons from three trials, p < 0.05, two-tailed t-test). However, there was a significant decrease in the colocalization of Syn with Bass-positive elements (Bass þ Syn; p < 0.05, two-tailed t-test) In other words, after Pb 2þ exposure, there is a greater number of Bass-positive putative presynaptic contact sites that lack Syn.
exposure, suggesting an increase in putative presynaptic contact sites. All data are shown as the mean ± SEM and are the result of at least three independent trials with three to six neurons per condition per trial. *p < 0.05 relative to control (Student's t-test). Scale bar ¼ 20 lm; dendritic regions enclosed by dashed rectangle shown magnified to right of image. -treated (H) neurons stained for VGAT (red) and Syn (green). Colocalization quantification is shown in (I) Syn þ VGAT corresponds to the amount of VGAT found with Syn-containing synapses, VGAT þ Syn corresponds to the amount of Syn found in VGAT-containing synapses, and VGAT alone corresponds to the amount of VGAT found in absence of Syn. Data are represented as the mean ± SEM of at least three independent trials with four to five neurons per condition per trial. *p < 0.05; **p < 0.01 compared with control (Student's two-tailed t-test). Scale bar ¼ 20 lm; dendritic regions enclosed by dashed rectangle shown magnified below image.
DISRUPTION OF SYNAPTIC FUNCTION BY LEAD
Glutamatergic and GABAergic Neurons Exhibit Loss of Synaptophysin after Pb 2þ Exposure
To explore the neuronal phenotype in which the levels of vesicular release proteins are affected, we investigated whether the reduction in Syn levels by Pb 2þ was specific to glutamatergic or GABAergic synapses, the two principal neuron types found in primary hippocampal cultures. We performed colocalization studies with either VGAT or VGLUT1 in combination with Syn. A significant number of VGAT-and VGLUT1-positive presynaptic elements did not contain Syn. This was indicated by the reduction of Syn found in VGLUT1-and VGAT-containing synapses and the increase in synapses which contained only the transporter protein and not Syn (Figs. 4D-I ). The magnitude of these effects was similar for both transporters indicating that both glutamatergic and GABAergic synapses may be affected by Pb 2þ exposure.
Vesicular Release Is Markedly Impaired in Pb 2þ -Exposed Neurons by Reducing the Number of Fast-Releasing Sites
The previous results provided strong evidence that vesicular release may be impaired in Pb 2þ -exposed cultures. Therefore, we performed live imaging studies with the fluorescent dye FM 1-43, which is taken up as synaptic vesicles recycle and is released when labeled vesicles undergo exocytosis as a function of network activity. The release kinetics of vesicle exocytosis can be recorded using confocal time-lapse microscopy. Representative time-lapse videos for both control and Pb 2þ -treated neurons are provided in Supplementary videos 1 and 2, respectively. The number of sites that released dye was obtained by subtracting the destained image from the initial time point of recording (see the ''Methods'' section and Fig. 1 ). As shown in Figure 5A , exposure to Pb 2þ significantly reduced the number of FM 1-43-labeled puncta by nearly 60% (n ¼ 11 neurons, three trials, p < 0.01, two-tailed t-test) relative to control neurons.
We also compared the rates of release for individual FM 1-43-labeled puncta from control neurons (98 sites in 12 neurons, three independent trials) and from neurons treated with Pb 2þ (75 sites in 11 neurons, three independent trials). The fluorescence decay of each site fit a single-exponential model after subtracting the rate of photobleaching. This allowed direct estimation of the rate constant (k) and mean lifetime (s or 1/k) of release (see Fig. 1 ). Comparing the frequency of s values for both control and Pb 2þ -treated cells revealed significant alterations in the distribution of s relative to control cells. The medians of the two distributions were significantly different (p < 0.001, Kruskal-Wallis test) with a median s value of 351 s for the control condition and a median s value of 476 s for the Pb 2þ -treated condition. To determine where the largest differences in the s distribution were, we split the control distribution into four quadrants based on its quartile values. These same values were used to split the Pb 2þ -treated s distribution. We observed that differences in the distribution in the first quadrant provided the highest contribution to the Pearson's chi-square test statistic (v 2 ¼ 15.4197, p ¼ 0.001), with fewer fast-releasing sites in the Pb 2þ -treated condition relative to control (Table 1 ). The fourth quadrant also contributed, although less so, to the Pearson's chi-square test statistic with more slow-releasing sites in the Pb 2þ -treated condition relative to control (Table 1) . We averaged the rate of release by pooling the fluorescent decay of all sites after normalizing each site to its initial fluorescence. There was a high degree of intra-cell correlation (q ¼ 0.27), necessitating the use of a model that incorporated clustering at the cellular level (see the ''Methods'' section). Figure 5B shows the overall rate of release for control and Pb The effect of Pb 2þ on the rate of vesicular release was likely not caused by changes in the size of the vesicle pool because of Pb 2þ exposure, as the initial intensity of the FM 1-43-stained sites (an indication of vesicle loading) did not change significantly after Pb 2þ exposure. Under control conditions, we observed an average FM 1-43 initial intensity of 20.1 ± 2.7 AU, whereas after exposure to 1.0lM Pb 2þ , the average FM 1-43 initial intensity was 16.1 ± 1.9 AU (n ¼ 11-12 neurons per condition, three trials, p > 0.05, two-tailed t-test).
NMDAR Inhibition Mimics the Effect of Pb 2þ on Synaptophysin
Changes in NMDAR activity can regulate presynaptic plasticity (Walz et al., 2006) , and Pb 2þ is a potent NMDAR antagonist (Alkondon et al., 1990; Gavazzo et al., 2008; Guilarte et al., 1994) . As such, Pb 2þ -induced changes observed in presynaptic elements could be mediated via NMDAR inhibition. To test this hypothesis, neurons were exposed to the selective NMDAR antagonist APV alone or in combination with Pb 2þ . If our hypothesis is correct, then APV exposure should mimic the effects of Pb 2þ on presynaptic proteins. APV treatment (100lM) during synaptogenesis decreased all Syn puncta characteristics, an effect that is identical to that produced by Pb 2þ treatment (Figs. 6A-E). Coexposure to both antagonists significantly reduced Syn puncta density, intensity, area, and TGV in a manner identical to Pb 2þ exposure (Fig. 6E) . The lack of additivity of the two antagonists supports our hypothesis that they share a common mechanism; i.e., reduction of NMDAR activity reduces Syn expression. Immunoblotting confirmed significant reduction of Syn levels (Figs. 6F and 6G; n ¼ 3 independent experiments, F 3,8 ¼ 5.15, p < 0.05). Thus, the effect of Pb 2þ on Syn can be mimicked by other NMDAR antagonists and is likely mediated by inhibition of NMDAR activity.
Cellular proBDNF Levels and BDNF Release Are Decreased in Pb 2þ -Exposed Neurons
Stabilization of presynaptic release sites is regulated by retrograde signals from the postsynaptic density (Carvalho et al., 2008; Fitzsimonds and Poo, 1998) . It is thought that the generation and release of the retrograde transsynaptic signaling molecule BDNF is regulated by NMDAR activation in the postsynaptic density (Bramham and Messaoudi, 2005; Vanhoutte and Bading, 2003; Walz et al., 2006) . Because our current findings suggest that the effects of Pb 2þ exposure on presynaptic plasticity are mediated by NMDAR inhibition, we hypothesized that these effects could be mediated by a deficit in BDNF signaling.
We investigated whether BDNF levels were affected by Pb 2þ exposure using the same experimental paradigm as described above, exposure to 1.0lM Pb 2þ from DIV7 to DIV12. Prior to release to the extracellular milieu, intracellular BDNF is often found as the proBDNF precursor (Carvalho et al., 2008) . As shown in Figures 7A and 7B , we observed that Pb 2þ exposure during this time period reduced whole-cell proBDNF levels significantly (n ¼ 5 independent trials, p < 0.05, two-tailed t-test). However, if Pb 2þ exposure affects presynaptic plasticity via inhibition of NMDAR activity-dependent BDNF signaling, then BDNF release may be impaired. To address this question, we performed ELISA assays to detect the amount of BDNF released into the medium from DIV7 to DIV12 in control and Pb 2þ -treated neurons. We observed a significant reduction of BDNF levels in the culture medium of Pb 2þ -treated cells relative to control (n ¼ 3 independent assays, p < 0.05, two-tailed t-test; Fig. 7C ). Together, these data strongly suggest that Pb 2þ -exposed neurons exhibit a deficit in both intracellular proBDNF protein levels and BDNF release during this period of synaptogenesis.
Exogenous BDNF Rescues Deficits in Synaptophysin and
Synaptobrevin Protein Levels and Impairments in Vesicular Release during Pb 2þ Exposure
Our previous data suggested that Pb 2þ -exposed neurons have decreased proBDNF protein levels and dampened BDNF release. This would indicate a deficit in BDNF signaling in Pb 2þ -exposed cultures that may be remediated by exogenous addition of BDNF. To determine if exogenous addition of BDNF could alleviate the effects of Pb 2þ exposure, we used the same experimental paradigm as described initially: a total exposure of 5 days to 1.0lM Pb 2þ . However, on exposure day 4, 25 ng/ml BDNF was added exogenously for the final 24 h of continuous Pb 2þ exposure. As shown in Figures 8A-E , we observed that The control distribution of s values was split into four quadrants corresponding to the quartile values. These same values were used to split the Pb 2þ distribution into four quadrants and the frequency of sites in each region was compared using Pearson's chi-square test. Exposure to Pb 2þ had a significantly different distribution of s values relative to the control distribution, with changes in the first and fourth quartile driving the differences. Specifically, Pb 2þ -treated neurons had fewer sites of fast release rates (Quartile 1) and more sites of slow release rates (Quartile 2). n ¼ 98 sites from 12 control cells and 75 sites from 11 Pb 2þ -treated cells.
DISRUPTION OF SYNAPTIC FUNCTION BY LEAD
Pb
2þ exposure alone reduced Syn levels visualized by immunocytochemistry in a manner consistent with our previous studies (Fig. 2) . Combined exposure to Pb 2þ and 25 ng/ml BDNF produced Syn levels indistinguishable from those in control cultures; thus, exogenous application of BDNF was sufficient to recover Syn during Pb 2þ exposure. Syb protein was also completely recovered in Pb 2þ -exposed neurons treated with BDNF (Figs. 8F-J) . Neurons exposed to Pb 2þ exhibited reduced Syb expression consistent with our previous studies (Figs. 3A-C) . However, in neurons exposed to both Pb 2þ and 25 ng/ml BDNF, Syb puncta density, puncta area, and puncta intensity increased to levels comparable with control. These data point to a deficit in BDNF signaling in Pb 2þ -exposed neurons and likely represent protein recovery because Syn and Syb protein levels visualized by immunocytochemistry are reduced relative to control conditions after 4 days of Pb 2þ exposure before addition of BDNF (Supplementary fig. 1 ). Thus, BDNF application is sufficient to recover both Syn and Syb levels during Pb 2þ exposure. After establishing that exogenous addition of BDNF for the final 24 h of Pb 2þ exposure was sufficient to recover presynaptic protein expression, we next investigated whether this treatment was sufficient to rescue the effects of Pb 2þ on vesicular release. FM 1-43 imaging was performed in the same manner as described above for control, 1.0lM Pb 2þ , 25 ng/ml BDNF, and 1.0lM Pb 2þ þ 25 ng/ml BDNF treatment groups. Representative videos of each treatment group can be viewed in Supplementary videos 3-6. As shown in Figure 8K , and consistent with the data in Figure 5 , Pb 2þ exposure significantly reduced the number of FM 1-43-labeled sites (n ¼ 10 cells; F 3,38 ¼ 3.29, p < 0.05), whereas combined exposure to Pb 2þ and BDNF did not significantly reduce the number of labeled sites.
Comparing the frequency of s values for the treatment conditions revealed significant alterations in the distribution of s. The medians of the distributions were significantly different (p < 0.05, Kruskal-Wallis test) with a median s value of 198.0 s for the control condition, 208.3 s for Pb 2þ , 212.8 s for BDNF, and 229.9 s for Pb 2þ þ BDNF treatment groups. These live imaging studies confirmed that Pb 2þ reduced the number of fast-releasing sites found in the first quartile of the control distribution (Table 2) . However, cotreatment with Pb 2þ and BDNF resulted in similar levels of fast-releasing sites as the control distribution. Interestingly, both groups which received BDNF treatment exhibited a large increase in the number of 258 very slow release sites as well as an increase in very fast release sites (Table 2) , which likely resulted in the higher median values in the BDNF treatment groups.
Finally, we compared the averaged rates of release between the four treatment groups (Fig. 8L) . Again, similar to our previous release studies (Fig. 5) 192.8 s [189.0-196.8] , n ¼ 176 sites from 11 cells), an effect likely because of the large number of very slow sites present in these conditions (see Table 2 ). However, the neurons treated with both Pb 2þ and BDNF were still significantly faster than neurons exposed to Pb 2þ alone (p < 0.0001, xtmixed linear regression, Stata v9.2).
Similar to our earlier live imaging studies, we did not observe a significant effect of Pb 2þ or BDNF treatment on the initial intensity of FM 1-43 staining. The average initial intensity of control (33.9 ± 2.1 AU), Pb 2þ -treated (51.2 ± 6.7 AU), BDNF-treated (38.3 ± 2.3 AU), and Pb 2þ þ BDNFtreated (40.6 ± 4.8 AU) neurons did not vary significantly between groups (n ¼ 9-11 neurons per condition, F 3,36 ¼ 2.58, p > 0.05). This suggests again that the differences in release rate observed in the treatment groups were not because of changes in the size of the vesicle pool.
In summary, exogenous application of BDNF for the final 24 h of Pb 2þ exposure is sufficient to recover both Syn and Syb protein levels as well as reverse the deficits observed in vesicular release in Pb 2þ -exposed neurons.
DISCUSSION
The present work provides the first mechanistic data to support previous observations of impaired presynaptic neurotransmission as a result of Pb 2þ exposure. Our results support the following conclusions: (1) Pb 2þ exposure during synaptogenesis decreases Syn and Syb proteins, resulting in impaired vesicular release. Furthermore, this effect was observed in both glutamatergic and GABAergic neurons. (2) Disruption of NMDAR activity-dependent BDNF signaling as measured by decreased cellular proBDNF levels and BDNF release may contribute to the effects of Pb 2þ on presynaptic plasticity and vesicular release. Nascent presynaptic sites often lack vesicular proteins, and one of the earliest markers of developing presynaptic contact sites is the structural protein Bass (Friedman et al., 2000; Shapira et al., 2003; Ziv and Garner, 2004) . We used the differential expression of synaptic proteins to determine if Pb 2þ affected the number of presynaptic sites (visualized by the staining of Bass), the recruitment of synaptic vesicles (visualized by several different vesicular proteins; Syn, Syb, Syt, VGLUT1, and VGAT) or expression of synaptic proteins that play a role in vesicular targeting and/or release (Syn, Syb, and Syt). Our work convincingly shows that Pb 2þ exposure may actually increase the number of synaptic contact sites (increased Bass staining) while not necessarily affecting the vesicle pool size because the puncta density and intensity of Syt, VGLUT1, or VGAT did change significantly (Fig. 3) and neither did the initial FM 1-43 dye intensity. However, Pb 2þ exposure did result in decreases in Syn and Syb levels, the number of fast-releasing sites, and slowed the average rate of vesicular release, suggesting that Pb 2þ has more specific effects on PAZ related to vesicle dynamics.
Interestingly, our data indicate that glutamatergic and GABAergic synapses may both be affected by Pb 2þ exposure. A decrease in the number of synapses that contain VGLUT1 or VGAT but not Syn indicates that even though the number of VGLUT1-or VGAT-positive synapses does not change (puncta density, Fig. 3 ), the loss of Syn-positive synapses (puncta density, Fig. 2 ) results in less synapses which contain both a neurotransmitter transporter and a Syn. This is supported by our observation that the number of presynaptic elements that contained both VGLUT1 and Syn as well as the number of elements containing both VGAT and Syn significantly decreased after Pb 2þ exposure (Fig. 4) . Thus, presynaptic elements from both the glutamatergic and GABAergic systems likely exhibit impaired neurotransmitter release, although our live imaging studies did not distinguish between the two types of synapses.
Our finding that the loss of Syn and Syb after Pb 2þ exposure results in impaired vesicular release is supported by several studies. Syn plays an important role in directing Syb to synaptic vesicles and may act as a chaperone in this regard (Valtorta et al., 2004) . Furthermore, in addition to assisting vesicle fusion with the plasma membrane, Syb may be responsible for segregating the readily releasable from the reserve vesicular pools (Sara et al., 2005) . Disruption of Syb fusion ability selectively reduces fast fusion events (Bretou et al., 2008) ; thus, the loss of Syb in Pb 2þ -exposed neurons may be directly relevant to the loss of fast-releasing vesicles during Pb 2þ exposure. The identification of fast-and slow-releasing vesicle pools in the present study is consistent with other studies in central , and Pb 2þ þ BDNF-treated neurons. All sites were normalized to their initial fluorescence and pooled. All treatments were significantly slower than the control condition (p < 0.0001), but the neurons treated with both BDNF and Pb 2þ exhibited a significantly faster rate of release than those treated with Pb 2þ alone. Predicted value of s shown with 95% confidence intervals (xtmixed, Stata v9.2). *Different from all other treatments (p < 0.05, Fisher's protected LSD). Scale bar ¼ 20 lm; dendritic regions enclosed by dashed rectangle shown magnified below image. 260 (Goda and Stevens, 1994) and calyx of Held synapses (Wadel et al., 2007) . Previous studies have shown that fast-releasing vesicles are responsible for synchronous release during an action potential, whereas asynchronous release is associated with slow-releasing sites. Because our data show that neurons exposed to Pb 2þ exhibit a loss of fast-releasing sites, this suggests that Pb 2þ decreases the readily releasable pool associated with synchronous release. This interpretation is consistent with our results showing that neurons exposed to Pb 2þ also have decreased levels of Syn and Syb proteins (Fig. 3) . However, our data also suggest that there is no change in the overall vesicle pool size because there were no significant differences in the initial intensity of the FM 1-43-stained sites under any of our conditions. The number of fast-releasing vesicles can be approximated by the number of vesicles docked at the active zone (Sun and Wu, 2001 ). Thus, it is possible that Pb 2þ -exposed neurons, which have decreased levels of Syb, may have a reduction of docked vesicles but possibly possess a larger reserve pool, which exhibits slower release kinetics. Studies using electron microscopy may provide key insights regarding the status of the vesicle pools after Pb 2þ exposure. Overall, our findings are consistent with studies indicating that Pb 2þ exposure alters neurotransmitter release (Braga et al., 1999; Lasley and Gilbert, 2002) . However, our results are the first to delineate a mechanism by which vesicular release is impaired.
Our conclusion that disruption of NMDAR activitydependent BDNF signaling may be impaired during Pb 2þ exposure is based on the following observations: In developing neurons, the stabilization of functional presynaptic release sites is controlled by retrograde signals from the postsynaptic density (Fitzsimonds and Poo, 1998; Verderio et al., 1999) . This retrograde signal can modulate formation and stabilization of developing synapses and is thought to be dependent upon the activation of postsynaptic NMDAR (Tao and Poo, 2001; Walz et al., 2006) . NMDAR activation is necessary for the generation and/or release of transsynaptic retrograde signaling molecules, such as BDNF (Hartmann et al., 2001; Jiang et al., 2005; Vanhoutte and Bading, 2003; Walz et al., 2006) , that modulate presynaptic plasticity. Inhibition of postsynaptic NMDAR reduces Syn and Syb levels and this deficit can be rescued by BDNF (Hu et al., 2005) , effects similar to those produced by Pb 2þ in the present study. Furthermore, BDNF knockout mice exhibit decreased Syn and Syb expression, reduced number of docked vesicles, and impairment in neurotransmitter release (Pozzo-Miller et al., 1999 ) that can be rescued by exogenous BDNF. Thus, there is evidence that postsynaptically released BDNF regulates the levels of presynaptic vesicular proteins, neurotransmitter release, and the stability of developing synapses (Hu et al., 2005; Tyler and Pozzo-Miller, 2001 ). Our findings of decreased cellular proBDNF levels as well as decreased BDNF release during Pb 2þ exposure are supported by preliminary studies by Lasley et al. (2008) , which showed that developmental Pb 2þ exposure decreases the activity-dependent release of BDNF in hippocampal slices. Together with our data showing that exogenous addition of BDNF can recover the effects of Pb 2þ , these findings support our hypothesis that NMDAR-dependent BDNF signaling is impaired by Pb 2þ exposure. Interestingly, BDNF alone did not affect the number of sites initially labeled with FM 1-43 (Fig. 8) , indicating that our BDNF treatment regimen does not necessarily promote genesis of new sites but may remediate ''silent'' sites in Pb 2þ -exposed neurons. The effects of Pb 2þ on presynaptic neurotransmitter release previously reported have been hypothesized to occur through inhibition of presynaptic Ca 2þ channels by Pb 2þ (Braga et al., 1999; Lasley and Gilbert, 2002; Xiao et al., 2006) . Although Pb 2þ does inhibit presynaptic Ca 2þ channels involved in The control distribution of s values was split into four quadrants corresponding to the quartile values. These same values were used to split the distributions of the treatment groups into four quadrants and the frequency of sites in each region was compared using Pearson's chi-square test. The distributions were significantly different from the control distribution. Similar to our previous results, changes in the first and fourth quartile were the driving force for the Pearson's test statistic. Specifically, Pb 2þ -treated neurons had fewer sites of fast release rates (Quartile 1) and more sites of slow release rates (Quartile 2). However, in cells that were exposed to both 1lM Pb 2þ and 25 ng/ml BDNF, the number of fast release sites was almost identical to control levels. Interestingly, both groups that received BDNF treatment exhibited more sites of very slow release. (Peng et al., 2002) , which may account for acute effects of Pb 2þ on neurotransmission, our comparison studies with the NMDAR-specific antagonist APV suggest that Pb 2þ -mediated inhibition of NMDARs is a viable alternative hypothesis to explain the presynaptic effects of Pb 2þ exposure. We observed that APV exposure, which does not inhibit presynaptic Ca 2þ channels, resulted in nearly identical effects on Syn expression as Pb 2þ exposure (Fig. 6 ). This suggests that NMDAR inhibition is at least partially responsible for the effects we have reported in these studies, although we cannot exclude the possibility that inhibition of Ca 2þ channels by Pb 2þ may also be involved in the underlying mechanism. It is important to consider that BDNF expression and release are dependent on intracellular Ca 2þ signaling (Hartmann et al., 2001; Shieh et al., 1998) ; thus, any Pb 2þ effect that results in decreased Ca 2þ influx, whether through block of NMDARs or Ca 2þ channels, may have detrimental effects on BDNF signaling essential to synaptic development. This hypothesis is supported by a recent study which demonstrated decreased dendritic BDNF release during exposure to APV or nimodipine, an L-type Ca 2þ channel antagonist (Matsuda et al., 2009 ). In summary, our results provide strong evidence that exposure to Pb 2þ disrupts developing synapses by altering the levels of selective synaptic proteins and impairing vesicular release, effects that may be mediated via NMDAR inhibition and disruption of BDNF signaling. Our studies suggest a molecular mechanism by which an environmental toxin is able to disrupt synapse formation and neuronal function, a central tenet of neurodevelopmental disorders.
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